Application of DUSP12 in hepatic ischemia reperfusion injury (IRI)
A 1.DUSP12, reperfusion injury technology, applied in the field of biomedicine, can solve the problem that the pathophysiological effect has not been fully confirmed, and achieve the effect of reducing liver ischemia-reperfusion injury
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0078] Below in conjunction with specific embodiment. To further set forth the present invention, it should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of protection of the present invention. The specific experimental conditions and methods not indicated in the following examples are usually according to conventional conditions such as: U.S. National The conditions described in the Guide for the Care and Use of Laboratory Animals of the Institute of Health; D.L. Spector et al., Science Press, 2001, Guidelines for Cell Experiments, etc., or as recommended by the manufacturer.
[0079] 1. Animal Models and Procedures
[0080] The generation of hepatocyte-specific DUSP12 knockout mice (CKO) and hepatocyte-specific DUSP12 transgenic mice (TG) was similar to previous experiments. CKO pups (Flox) and TG pups (NTG) were used as controls. The experiments were carried out in the Animal Experiment Center o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com